Igniting Innovation.
Transforming
Healthcare.
Investing in Tomorrow's Breakthroughs Today
About
Us
Highcroft Capital is a venture capital fund specializing in early-stage investments in medtech companies. Our team of physician investors has unparalleled industry insights and access to deal flow based on who we are. We evaluate companies not just as investors, but as users of these technologies. Our mission is to provide investors with access to venture capital investment opportunities that will transform the medical industry. With us, you'll get access to innovative and disruptive technologies that have the potential to make the impossible possible.
Physician Founded
Physician Funded
Physician Led
Our Team
Our partners comprise seasoned industry experts, visionary entrepreneurs, and strategic investors collectively leveraging their unique backgrounds to identify and support pioneering ventures in the dynamic realm of medical technology.
Investment Philosophy
Our investment philosophy extends beyond mere financial returns; we're driven by a commitment to advancing the standard of care and facilitating access to venture capital opportunities in healthcare. Leveraging our distinctive perspective, we prioritize accelerating game-changing products and technologies with the potential to reshape the industry landscape. Companies and fellow venture capital investors seek our involvement not only as a source of funds but also for the invaluable expertise and affiliations we bring to the table.
.png)
Fund I Investments
7x
3x
Active
Active
Active
Fund II Investment Details
With a planned fund size ranging from $3M to $5M, our venture capital endeavor is structured to accommodate up to 99 Accredited Investor Limited Partners, fostering a diverse and robust investor base. To date, we've successfully raised over $1M from more than 30 Limited Partners, signaling strong confidence in our investment strategy and approach.
We prioritize accessibility for our investors, implementing reasonable minimum investment requirements to ensure broad participation and inclusivity within our fund. Our investment model adheres to a 3 to 5-year investment period, with an expected fund duration of 10 years, aligning with industry standards while maximizing potential returns for our partners.
In terms of operational efficiency and transparency, we employ industry-standard investor management, tracking, compliance, and tax software, ensuring streamlined processes and adherence to regulatory requirements. Additionally, our management fees stand at 2%, consistent with industry norms, alongside a carried interest of 20%, reflecting our commitment to aligning incentives and driving mutual success for our investors and portfolio companies.
Fund II Investments to Date
